Publications

AACR-NCI-EORTC
Publications
Proteomics platform identifies vulnerabilities for DNA damage repair drugs
October 16, 2023
AACR-NCI-EORTC
Proteomics platform identifies vulnerabilities for DNA damage repair drugs
October 16, 2023
MCP
Publications
Functional impact of protein-RNA variation in clinical cancer analyses
June 8, 2023
MCP
Functional impact of protein-RNA variation in clinical cancer analyses
June 8, 2023
AACR 2023 meeting
Publications
AACR 2023- Predictive biomarker discovery method to bridge the gap between preclinical disease model dose-response and clinical trials
April 18, 2023
AACR 2023 meeting
AACR 2023- Predictive biomarker discovery method to bridge the gap between preclinical disease model dose-response and clinical trials
April 18, 2023
AACR 203 meeting
Publications
AACR 2023- What can we learn from phosphoproteomics compared to transcriptomics in DNA damage and other processes?
April 18, 2023
AACR 203 meeting
AACR 2023- What can we learn from phosphoproteomics compared to transcriptomics in DNA damage and other processes?
April 18, 2023
ASMS 2022
Publications
ASMS 2022- Artifical intelligence and proteomics: predicting genome-wide perturbation response
March 4, 2023
ASMS 2022
ASMS 2022- Artifical intelligence and proteomics: predicting genome-wide perturbation response
March 4, 2023
Cell logo
Publications
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
March 2, 2023
Cell logo
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
March 2, 2023
AACR Logo
Publications
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
March 2, 2023
AACR Logo
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
March 2, 2023
Cell Reports
Publications
Proteogenomics of glioblastoma associates molecular patterns with survival
March 2, 2023
Cell Reports
Proteogenomics of glioblastoma associates molecular patterns with survival
March 2, 2023

Let's talk

Get in touch with us for questions and potential collaborations.